A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis
Clinical trial NCT04956744 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04956744
- Sponsor
- ImStem Biotechnology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2027-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.